Project Echo: Tele-mentoring to manage immune-related adverse events in patients receiving cancer immunotherapies: Endocrine Toxicities with Immune Checkpoint Inhibitors - November 15, 2022
This page is for learners who attended the November 15, 2022, virtual session to claim credit.
The target audience for this initiative includes oncologists, oncology advanced practice providers (nurse practitioners, physician assistants), oncology pharmacists, oncology nurses, and other healthcare professionals (HCPs) involved in treating patients with cancer immunotherapies.
- Apply evidence-based practices for the monitoring and management of irAEs in patients receiving cancer immunotherapies
- Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAEs in patients receiving cancer immunotherapies
- Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based educational activity. Pharmacists will receive 1.0 contact hour (0.10 CEUS) for the educational activity. No partial credit is available.
UNIVERSAL ACTIVITY NUMBERS (UAN) 0060-9999-22-085-L01-P
Please see the additional information tab in the Overview section for directions on how to claim credit.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 Participation
The activity has been provided by an educational grant from BMS.